These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18318147)

  • 21. Severe community acquired pneumonia.
    Mills GD; Laing R
    BMJ; 2006 Dec; 333(7580):1181-2. PubMed ID: 17158360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are new antibiotics better than beta-lactams for non-critical inpatients with community-acquired pneumonia?
    Reyes B T; Ortega G M; Saldías P F
    Medwave; 2016 Aug; 16 Suppl 3():e6499. PubMed ID: 27512983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monotherapy in severe community-acquired pneumonia: is it worthy?
    Torres A
    Chest; 2005 Jul; 128(1):10-3. PubMed ID: 16002907
    [No Abstract]   [Full Text] [Related]  

  • 24. When to switch therapy in patients with severe community-acquired pneumonia.
    Mortensen EM; Restrepo MI; Anzueto A
    Ann Intern Med; 2008 Apr; 148(8):625; author reply 625-6. PubMed ID: 18413627
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical efficacy of clarithromycin delayed release dosage form in the treatment of community-acquired pneumonia].
    Iutanova NS
    Antibiot Khimioter; 2004; 49(3):17-21. PubMed ID: 15344392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azithromycin versus comparative therapy for the treatment of community acquired pneumonia.
    Rahav G; Fidel J; Gibor Y; Shapiro M
    Int J Antimicrob Agents; 2004 Aug; 24(2):181-4. PubMed ID: 15288319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unforeseen risk in the treatment of severe community-acquired pneumonia with narrow-spectrum antibiotics.
    Folb J; Potter L; Roberts S; Shaw R; Kent W; Vaudrey K
    J Antimicrob Chemother; 2014 Jul; 69(7):2013-4. PubMed ID: 24595803
    [No Abstract]   [Full Text] [Related]  

  • 28. Routine atypical antibiotic coverage is not necessary in hospitalised patients with non-severe community-acquired pneumonia.
    Naucler P; Strålin K
    Int J Antimicrob Agents; 2016 Aug; 48(2):224-5. PubMed ID: 27374746
    [No Abstract]   [Full Text] [Related]  

  • 29. Doxycycline for nursing home acquired pneumonia (NHAP).
    Cunha BA
    Scand J Infect Dis; 2009; 41(1):77-8, author reply 76. PubMed ID: 18821134
    [No Abstract]   [Full Text] [Related]  

  • 30. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
    Esposito S; Fiore M
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
    [No Abstract]   [Full Text] [Related]  

  • 31. Changing needs of community-acquired bacterial pneumonia: experience with ceftaroline fosamil. Preface.
    Johnson AP; Leibovici L
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii1. PubMed ID: 21548186
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibiotic therapy for community-acquired pneumonia with septic shock: follow the guidelines.
    Blot S; Depuydt P
    Crit Care Med; 2007 Jun; 35(6):1617-8. PubMed ID: 17522537
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy for ambulatory infectious pneumonia].
    Stollewerk D
    Pneumologie; 2008 Dec; 62(12):744; author reply 744. PubMed ID: 19051156
    [No Abstract]   [Full Text] [Related]  

  • 34. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.
    Nakamura S; Yanagihara K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Senjyu H; Saito A; Kohno S
    J Infect; 2009 Sep; 59(3):222-4. PubMed ID: 19592113
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative analysis of the treatment of inpatients with community-acquired pneumonia and its different outcomes].
    Vizel' AA; Lysenko GV
    Klin Med (Mosk); 2013; 91(3):41-4. PubMed ID: 23789451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of Antibiotic Treatment in Community-Acquired Pneumonia.
    Uranga Echeverría A
    Arch Bronconeumol; 2015 Dec; 51(12):613-4. PubMed ID: 25769445
    [No Abstract]   [Full Text] [Related]  

  • 37. Fluoroquinolones in the management of community-acquired pneumonia.
    Albertson TE; Dean NC; El Solh AA; Gotfried MH; Kaplan C; Niederman MS
    Int J Clin Pract; 2010 Feb; 64(3):378-88. PubMed ID: 20456176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community acquired pneumonia.
    Loeb M
    Clin Evid; 2002 Jun; (7):1358-68. PubMed ID: 12230751
    [No Abstract]   [Full Text] [Related]  

  • 39. [The antibacterial therapy of severe pneumonia].
    Iakovlev SV
    Antibiot Khimioter; 2000; 45(6):40-4. PubMed ID: 10904809
    [No Abstract]   [Full Text] [Related]  

  • 40. Does guideline adherence for empiric antibiotic therapy reduce mortality in community-acquired pneumonia?
    Aujesky D; Fine MJ
    Am J Respir Crit Care Med; 2005 Sep; 172(6):655-6. PubMed ID: 16148192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.